share_log

Baosheng Science and Technology InnovationLtd (SHSE:600973) Delivers Shareholders 4.3% CAGR Over 5 Years, Surging 7.4% in the Last Week Alone

Baosheng Science and Technology InnovationLtd (SHSE:600973) Delivers Shareholders 4.3% CAGR Over 5 Years, Surging 7.4% in the Last Week Alone

寶勝科技創新有限公司(SHSE:600973)在過去5年內爲股東提供了4.3%的年複合增長率,僅上週漲幅達7.4%
Simply Wall St ·  2024/11/06 06:23

Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Baosheng Science and Technology Innovation Co.,Ltd. (SHSE:600973) share price is up 21% in the last five years, slightly above the market return. In stark contrast, the stock price has actually fallen 15% in the last year.

passive index funds的投資能夠獲得與整體市場大致相匹配的回報。 但事實是,如果你以適當價格買入優質企業,你可以獲得顯著的收益。 舉例來說,寶勝股份(SHSE:600973)的股價在過去五年上漲了21%,略高於市場回報。 相比之下,該股票價格在過去一年實際下跌了15%。

The past week has proven to be lucrative for Baosheng Science and Technology InnovationLtd investors, so let's see if fundamentals drove the company's five-year performance.

過去一週對於寶勝科技創新股票投資者來說是有利可圖的,讓我們看看公司的五年業績是否受基本面驅動。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

儘管市場是一個強大的定價機制,股價不僅反映了基本業務表現,還反映了投資者的情緒。通過比較每股收益(EPS)和股價變化,並隨時間推移這樣做,我們可以了解股東對公司的態度如何隨時間變化。

Baosheng Science and Technology InnovationLtd's earnings per share are down 20% per year, despite strong share price performance over five years.

儘管在過去五年中股價表現強勁,寶勝科技創新有限公司的每股收益每年下降20%。

Since the EPS are down strongly, it seems highly unlikely market participants are looking at EPS to value the company. The falling EPS doesn't correlate with the climbing share price, so it's worth taking a look at other metrics.

由於每股收益大幅下滑,市場參與者看待公司的價值不可能僅僅考慮每股收益。下跌的每股收益與上漲的股價並不相關,因此值得關注其他指標。

In contrast revenue growth of 6.7% per year is probably viewed as evidence that Baosheng Science and Technology InnovationLtd is growing, a real positive. It's quite possible that management are prioritizing revenue growth over EPS growth at the moment.

相比每年6.7%的營業收入增長,寶勝股份的增長可能被視爲證據,表明它正在增長,這是一個真正的積極信號。目前管理層很可能優先考慮營業收入增長,而非每股收益增長。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下方圖片中看到盈利和營業收入隨時間的變化(單擊圖表查看準確數值)。

big
SHSE:600973 Earnings and Revenue Growth November 5th 2024
SHSE:600973 盈利和營收增長2024年11月5日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表實力非常重要。查看我們關於其財務狀況如何隨時間變化的免費報告可能非常值得。

What About The Total Shareholder Return (TSR)?

那麼,股東總回報(TSR)呢?

We've already covered Baosheng Science and Technology InnovationLtd's share price action, but we should also mention its total shareholder return (TSR). Arguably the TSR is a more complete return calculation because it accounts for the value of dividends (as if they were reinvested), along with the hypothetical value of any discounted capital that have been offered to shareholders. Dividends have been really beneficial for Baosheng Science and Technology InnovationLtd shareholders, and that cash payout contributed to why its TSR of 23%, over the last 5 years, is better than the share price return.

我們已經提到了寶勝股份的股價表現,但我們也應該提到其總股東回報率(TSR)。可以說TSR是一種更完整的回報計算,因爲它考慮了股息的價值(就好像它們被再投資了),以及向股東提供的任何折現資本的假設價值。分紅對寶勝股份的股東們確實非常有利,這筆現金支付有助於解釋爲什麼過去5年裏其TSR達到了23%,比股價回報要好。

A Different Perspective

另一種看法

Baosheng Science and Technology InnovationLtd shareholders are down 15% for the year, but the market itself is up 5.1%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 4% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 1 warning sign for Baosheng Science and Technology InnovationLtd you should be aware of.

寶勝股份股東今年下降了15%,但市場本身上漲了5.1%。即使是好股票的股價有時也會下跌,但我們希望在對一個業務的基本指標有所改善之前,不要過於感興趣。從好的一面來看,長期股東賺錢了,過去半個十年每年增長4%。最近的拋售可能是一個機會,因此值得檢查基本數據,以發現長期增長趨勢的跡象。雖然值得考慮市場狀況對股價可能產生的不同影響,但有其他更重要的因素。例如:我們發現了寶勝股份股東應該注意的1個警示信號。

But note: Baosheng Science and Technology InnovationLtd may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但需要注意:寶勝股份可能不是最好的股票選擇。因此,請查看這份免費的有過往盈利增長(以及未來增長預測)的有趣公司名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文中引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論